Ozkanli F, Dalkara S, Caliş U, Willke A
University of Hacettepe, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey.
Arzneimittelforschung. 1994 Aug;44(8):920-4.
Some new N-arylazole acetamide derivatives have been prepared by the reaction of alpha-bromo-N-arylacetamide with imidazole, pyrazole and 1,2,4-triazole. The structures of these compounds have been confirmed by UV, IR, 1H-NMR and elementary analysis. Their anticonvulsant activities were determined by maximal electroshock (MES) and subcutaneous metrazol (Scmet) tests. Most of the compounds showed anticonvulsant activity with significantly low neurotoxicity according to Phase I tests. Compound 6 carrying alpha-naphthyl and 1,2,4-triazole was found active in the MES test with ED50 = 64.9 mg/kg and TD50 = 221.0 mg/kg but it was not active in corneally stimulated rats. Antibacterial and antifungal activities of the compounds were determined against S. aureus, E. coli, P. aeruginosa, C. albicans, C. parapsilosis, C. pseudotropicalis and C. stellatoidea by using the microdilution broth method. Compounds 8 and 10 showed significant activity (MIC < 32 micrograms/ml) against various Candida species.
通过α-溴代-N-芳基乙酰胺与咪唑、吡唑和1,2,4-三唑反应制备了一些新型N-芳基唑乙酰胺衍生物。这些化合物的结构已通过紫外光谱、红外光谱、1H-核磁共振和元素分析得以确证。它们的抗惊厥活性通过最大电休克(MES)和皮下注射戊四氮(Scmet)试验来测定。根据I期试验,大多数化合物显示出抗惊厥活性且神经毒性显著较低。带有α-萘基和1,2,4-三唑的化合物6在MES试验中具有活性,ED50 = 64.9 mg/kg,TD50 = 221.0 mg/kg,但在角膜刺激大鼠中无活性。采用微量稀释肉汤法测定了这些化合物对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌、白色念珠菌、近平滑念珠菌、伪热带念珠菌和星状念珠菌的抗菌和抗真菌活性。化合物8和10对各种念珠菌属显示出显著活性(MIC < 32微克/毫升)。